$ISRG
Intuitive Surgical, Inc. · NasdaqGS · Healthcare
- Market cap
- 159.78B
- Volume
- 3.00M
- P/E
- 54.69
- Day range
- 442.56 – 458.45
- 52w range
- 328.57 – 603.88
- Analyst target
- 478.30
AI Summary
Generating a unique summary for ISRG…
AI-generated for information only — not investment advice.
Share this ticker
$ISRG +1.90% at 452.29 Warren Buffett and 3 other tracked billionaires hold it. $JNJ $NTRA $LLY https://billionairestrading.com/stocks/ISRG
Company summary
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.
Institutional ownership
Institutions hold 91.21% · insiders 0.52% · 3,127 institutions
| Holder | Shares | Value | % held | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 30.02M | $13.58B | 8.66% | 2026-06-30 |
| Vanguard Capital Management LLC | 23.13M | $10.46B | 6.67% | 2026-06-30 |
| State Street Corporation | 16.06M | $7.27B | 4.63% | 2026-06-30 |
| Invesco Ltd. | 11.84M | $5.36B | 3.42% | 2026-06-30 |
| Price (T.Rowe) Associates Inc | 11.26M | $5.09B | 3.25% | 2026-06-30 |
| Geode Capital Management, LLC | 8.53M | $3.86B | 2.46% | 2026-06-30 |
| Capital World Investors | 7.74M | $3.50B | 2.23% | 2026-06-30 |
| Vanguard Portfolio Management LLC | 7.24M | $3.28B | 2.09% | 2026-06-30 |
| Morgan Stanley | 6.56M | $2.97B | 1.89% | 2026-06-30 |
| NORGES BANK | 4.95M | $2.24B | 1.43% | 2026-06-30 |
Hedge fund & billionaire activity
Insider transactions
| Insider | Role | Transaction | Shares | Date |
|---|---|---|---|---|
| LOEB GARY | Officer | — | 2.6K | 2026-10-09 |
| WADORS PATRICIA L. | Officer | — | 2.1K | 2026-10-09 |
| WIDMAN FREDRIK | Officer | Sale at price 374.44 per share. | 1.1K | 2026-09-15 |
| WIDMAN FREDRIK | Officer | Conversion of Exercise of derivative security at price 79.64 - 109.49 per share. | 1.1K | 2026-09-15 |
| BROSIUS MARK PRESTON | Officer | Sale at price 347.66 - 365.79 per share. | 48.00 | 2026-09-11 |
| BROSIUS MARK PRESTON | Officer | Sale at price 350.20 - 361.23 per share. | 69.00 | 2026-09-09 |
| BROSIUS MARK PRESTON | Officer | Sale at price 375.57 - 396.37 per share. | 154.00 | 2026-08-21 |
| BROSIUS MARK PRESTON | Officer | Sale at price 390.67 - 394.26 per share. | 231.00 | 2026-08-19 |
| LADD AMY L | Director | Sale at price 379.00 - 393.10 per share. | 472.00 | 2026-08-11 |
| GUTHART GARY S | Director | Sale at price 400.00 per share. | 10.0K | 2026-08-11 |
| LOEB GARY | Officer | Sale at price 379.00 per share. | 400.00 | 2026-08-10 |
| BROSIUS MARK PRESTON | Officer | Sale at price 346.83 - 351.00 per share. | 56.00 | 2026-07-31 |
Analyst ratings
Consensus score 1.76 (1 = strong buy, 5 = sell) · mean target 478.30
- Leerink PartnersOutperformmain2026-10-21
- JP MorganOverweightmain2026-10-21
- Evercore ISI GroupIn-Linemain2026-10-21
- Wells FargoOverweightmain2026-10-21
- TD CowenBuyreit2026-10-21
- BarclaysOverweightmain2026-10-21
- RBC CapitalOutperformmain2026-10-21
- MizuhoNeutralmain2026-10-21
- BairdOutperformmain2026-10-21
- BTIGBuyreit2026-10-21
Earnings
Next report: 2027-01-21
| Quarter | EPS actual | EPS estimate | Surprise |
|---|---|---|---|
| 4Q2025 | 2.53 | 2.27 | 0.26 |
| 1Q2026 | 2.50 | 2.11 | 0.39 |
| 2Q2026 | 2.80 | 2.50 | 0.30 |
| 3Q2026 | 3.00 | 2.64 | 0.36 |
SEC filings
- 10-QPeriodic Financial Reports2026-10-21Open
- 8-KCorporate Changes & Voting Matters2026-10-20Open
- 8-KCorporate Changes & Voting Matters2026-07-27Open
- S-8Offering Registrations2026-07-21Open
- 8-KCorporate Changes & Voting Matters2026-07-16Open
- 8-KCorporate Changes & Voting Matters2026-05-28Open
- SDSpecialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)2026-05-21Open
- 8-KCorporate Changes & Voting Matters2026-05-04Open
- 10-QPeriodic Financial Reports2026-04-22Open
- 8-KCorporate Changes & Voting Matters2026-04-21Open
Latest ISRG news
- Intuitive Surgical Sinks 6% as U.S. da Vinci Growth Slows to “Lowest We’ve Seen Since COVID”
Key TakeawaysIntuitive Surgical shares fell 6% today after U. S.
Fri, 23 Oct 2026 17:08:50 +0000
- How Has Intuitive Surgical's Story Changed?
For questions about this article or underlying research, email help@trefis.com.
Thu, 22 Oct 2026 11:08:46 +0000
- Intuitive Surgical (ISRG) Stock Faces A Q3 Earnings Valuation Reality Check
Intuitive Surgical stock came into Thursday with strong recent momentum, then slipped about 2% after the market had its first clean look at Q3 2026 numbers. The initial reaction focused on the headline gap between rich expectations and reality. The company delivered roughly US$3.0b in quarterly revenue and about US$1.50 in basic earnings per share, solid figures for a surgical robotics leader but less thrilling next to a P/E multiple above 50x. Short-term traders are fixated on that...
Thu, 22 Oct 2026 10:10:37 +0000
- Intuitive Surgical Hammered As Elevated Buy-Side Views Outshine Solid Numbers
Intuitive Surgical stock tumbled Wednesday as elevated expectations from the buy-side hampered the solid third-quarter report.
Wed, 21 Oct 2026 20:03:21 +0000
- ISRG Q3 deep dive: margin pressure overshadows strong adoption and international growth
Medical technology company Intuitive Surgical (NASDAQ:ISRG) beat Wall Street’s revenue expectations in Q3 2026, with sales up 21.7% year on year to $3.05 billion. Its non-GAAP profit of $3 per share was 13.6% above analysts’ consensus estimates.
Wed, 21 Oct 2026 19:42:39 +0000
- Intuitive Surgical to Face Potential Risks in 2027 Procedure Momentum From Pricing Actions, RBC Says
Intuitive Surgical (ISRG) will face potential risks to its 2027 procedure momentum from pricing acti
Wed, 21 Oct 2026 16:00:41 +0000
- Intuitive Surgical: 3 Key Takeaways for Long-Term Investors
Resolving a major litigation settlement while expanding into cost-sensitive outpatient centers positions the company for sustained procedure growth.
Wed, 21 Oct 2026 15:58:01 +0000
- Intuitive Surgical (ISRG) Q3 2026 Earnings Call Transcript
Revenue hit $3.05 billion as procedure volumes surged and system placements accelerated.
Wed, 21 Oct 2026 14:28:54 +0000